Literature DB >> 29964042

Are We Close to Targeting Enteric Glia in Gastrointestinal Diseases and Motility Disorders?

Brian D Gulbransen1, Fievos L Christofi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29964042      PMCID： PMC6452442          DOI： 10.1053/j.gastro.2018.06.050

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

Review 1.  Enteric neuroplasticity and dysmotility in inflammatory disease: key players and possible therapeutic targets.

Authors:  Estelle T Spear; Gary M Mawe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-10-11       Impact factor: 4.052

2.  Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity.

Authors:  Vanessa D'Antongiovanni; Laura Benvenuti; Matteo Fornai; Carolina Pellegrini; Renè van den Wijngaard; Silvia Cerantola; Maria Cecilia Giron; Valentina Caputi; Rocchina Colucci; Gyorgy Haskó; Zoltán H Németh; Corrado Blandizzi; Luca Antonioli
Journal:  Cells       Date:  2020-05-18       Impact factor: 6.600

Review 3.  Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System.

Authors:  Pavithra Chandramowlishwaran; Anitha Vijay; Daniel Abraham; Ge Li; Simon Musyoka Mwangi; Shanthi Srinivasan
Journal:  Front Neurosci       Date:  2020-12-22       Impact factor: 4.677

Review 4.  AAV Targeting of Glial Cell Types in the Central and Peripheral Nervous System and Relevance to Human Gene Therapy.

Authors:  Simon J O'Carroll; William H Cook; Deborah Young
Journal:  Front Mol Neurosci       Date:  2021-01-11       Impact factor: 5.639

Review 5.  Postoperative Ileus and Postoperative Gastrointestinal Tract Dysfunction: Pathogenic Mechanisms and Novel Treatment Strategies Beyond Colorectal Enhanced Recovery After Surgery Protocols.

Authors:  Elvio Mazzotta; Egina Criseida Villalobos-Hernandez; Juan Fiorda-Diaz; Alan Harzman; Fievos L Christofi
Journal:  Front Pharmacol       Date:  2020-11-24       Impact factor: 5.810

Review 6.  Molecular and cellular mechanisms underlying postoperative paralytic ileus by various immune cell types.

Authors:  Chao Sui; Liang Tao; Chunhua Bai; Lihua Shao; Ji Miao; Kai Chen; Meng Wang; Qiongyuan Hu; Feng Wang
Journal:  Front Pharmacol       Date:  2022-08-03       Impact factor: 5.988

7.  IL-1-dependent enteric gliosis guides intestinal inflammation and dysmotility and modulates macrophage function.

Authors:  Fievos L Christofi; Sven Wehner; Reiner Schneider; Patrick Leven; Shilpashree Mallesh; Mona Breßer; Linda Schneider; Elvio Mazzotta; Paola Fadda; Tim Glowka; Tim O Vilz; Philipp Lingohr; Jörg C Kalff
Journal:  Commun Biol       Date:  2022-08-12

8.  Role of Pannexin-1-P2X7R signaling on cell death and pro-inflammatory mediator expression induced by Clostridioides difficile toxins in enteric glia.

Authors:  Andrea V Loureiro; Lauro I Moura-Neto; Conceição S Martins; Pedro I M Silva; Matheus B S Lopes; Renata F C Leitão; Juliana M Coelho-Aguiar; Vivaldo Moura-Neto; Cirle A Warren; Deiziane V S Costa; Gerly A C Brito
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

9.  Interaction between the Renin-Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of Colitis.

Authors:  Mariana Ferreira-Duarte; Tiago Rodrigues-Pinto; Teresa Sousa; Miguel A Faria; Maria Sofia Rocha; Daniela Menezes-Pinto; Marisa Esteves-Monteiro; Fernando Magro; Patrícia Dias-Pereira; Margarida Duarte-Araújo; Manuela Morato
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

10.  A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation.

Authors:  Reiner Schneider; Patrick Leven; Tim Glowka; Ivan Kuzmanov; Mariola Lysson; Bianca Schneiker; Anna Miesen; Younis Baqi; Claudia Spanier; Iveta Grants; Elvio Mazzotta; Egina Villalobos-Hernandez; Jörg C Kalff; Christa E Müller; Fedias L Christofi; Sven Wehner
Journal:  EMBO Mol Med       Date:  2020-12-17       Impact factor: 14.260
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.